February 2019

February 14, 2019

February 13, 2019

We surveyed biopharmaceutical manufacturers and payers to understand the prevalence and characteristics of value-based payment arrangements, as well as their implementation obstacles and success factors.

February 12, 2019

This qualitative study finds low employer adoption of reference-based pricing (RBP) benefit design and that redesign of RBP may be necessary to overcome barriers to adoption.

February 11, 2019

Physician-level medication adherence is a strong predictor of patient health and should be considered as a measure of physician quality.

February 08, 2019

Cost-benefit analysis for quality measures has emerged as the cornerstone of CMS’ Meaningful Measures initiative.

February 07, 2019

The Medicaid population has significantly higher hepatitis C virus (HCV) prevalence and mortality rates than patients with private insurance. These data must be considered when policy makers assess providing additional support to Medicaid programs for HCV elimination.

February 06, 2019

Improving efficiency is complex and requires a multimodal approach. Health information systems, patient feedback, and multidisciplinary teams are components that can improve clinical processes.

February 05, 2019

When we weighted health insurance claims with a disease burden score, we were able to generate valid estimates of disability-adjusted life-years.

February 04, 2019

This randomized controlled trial finds that a hospital cesarean delivery rate comparison tool affects women’s perceptions but not where they choose to deliver.

February 01, 2019

We present an International Classification of Diseases, Tenth Revision (ICD-10) translation of the adapted Diabetes Complications Severity Index and show its performance in predicting hospitalizations, mortality, and healthcare-associated costs.

January 31, 2019

Value-based payment is promoting care delivery transformation among California physician organizations, although the initial focus has been on controlling hospital costs and redesigning primary care.

January 30, 2019

When it comes to the political iceberg of drug prices, there is more than meets the eye. Policies that reduce prices but do not lower consumers’ out-of-pocket costs will not address the main challenge facing most Americans.